AR and prostate carcinoma: Androgen receptor signaling is a key factor in many metastatic castration-resistant prostate cancers; the androgen receptor may be overexpressed, mutated, and possibly activated by the androgens produced by tumor cells in progressive disease (Scher et al., 2010; Vogelzang, 2012).